Physicians' Academy for Cardiovascular Education

Promise of epigenetic modulation as a target in atherosclerotic patients

Aug. 26, 2017 - Barcelona, Spain - Erik SG Stroes, MD, Amsterdam, the Netherlands - PACE-CME symposium at ESC 2017

This lecture was part of a CME accredited symposium: Managing Diabetes & CVD: Is epigenetics a new way forward? held at ESC 2017 in Barcelona

Video navigation menu

  • The prominent role of inflammation in atherogenesis 0:29
  • How to target the inflammatory processes with therapy? 3:01
  • What happens at the DNA/chromatin level during epigenetic gene regulation? 5:24
  • Aberrant epigenetic modifications in atherosclerotic disease 7:52
  • Experimental results with interfering with epigenetic processes 10:16

Educational information

The educational objectives of this symposium were to:

Faculty

Erik Stroes, MD, is Internist Vascular Medicine, Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands

CME Accreditation

This programme was accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credit(s).

Disclosures

This symposum was supported by an unrestricted educational grant provided by Resverlogix

Biography, Abstract and Keyslides View slides of this lecture